Marketing Copy Exercise

Marketing One-Pager: "Seed Spine"

A classroom exercise in constructing competitive, clinical, and testimonial marketing copy, demonstrating how persuasive medical-device claims are built, structured, and (importantly) how they should be scrutinized.

  • Course: Marketing Aspects of Biotechnology
  • Institution: Johns Hopkins University
  • Presented: August 4, 2024
Classroom exercise: fabricated content

"Seed Spine" is a fictional product and this one-pager was built as a class assignment in constructing marketing copy. Every element below, the competitive claims, the clinical statistics, the physician testimonials, the cited "journals," and the referenced study data, is fabricated for the assignment. Nothing here is a real clinical finding, a real endorsement, or a real product. Even the surgeon names and journal titles are intentionally invented (and satirical). It is included in this portfolio to demonstrate familiarity with how marketing claims are assembled, not to make any factual assertion.

Product concept

Seed Spine (branded under "Nikas") is presented as a line of minimally invasive, expandable spine rods for pediatric patients with severe early-onset scoliosis. The headline copy reads: "Flawlessly plant the revolutionary seed that turns patients into future Olympians." The one-pager positions Seed Spine against Nuvasive's MAGEC rods.

Competitive claims (as written, fabricated)

Physician testimonials (fictional characters)

"With my Harvard and MIT background, this is the most innovational implant I recommend for my patients." "Dr. Knot Reel, MD, MBA, PhD"
"If I used any other expandable rod system, my patient would have never won a gold medal in swimming at the Olympics." "Dr. Avoidnew Vasive, DO, MPH"

Note the deliberately satirical, pun-based names, a signal that these endorsements are invented for the exercise.

Clinical claims (fabricated statistics)

1 · Incision size & infection

Incisions needed for Seed Spine implantation are claimed to be 50% smaller than those in MAGEC implantation. Further, the copy claims 0.3% of MAGEC rods resulted in post-op infection compared to 0.15% of Seed Spine rods.(a)

2 · Sterile-processing compatibility

Sterile-processing compatibility affects surgical cases by delaying or cancelling them. The copy claims 23% of MAGEC rods fail sterilization versus a mere 9% of Seed Spine rods, describing Seed Spine as decontamination-, assembly-, and sterilization-friendly.(b)

3 · Radiation & imaging

The copy claims 80% of MAGEC user-surgeons report using X-rays for at least 75% of a MAGEC installation, versus only 10% of Seed Spine surgeons reporting X-ray use for 5% of a Seed Spine installation. The stated rationale: Seed Spine can be seen under UV light in the office and OR, and grows and disintegrates on its own, so fewer X-rays are needed.(c)

How the sources are presented

The one-pager cites invented "clinical" sources and discloses that its imagery was AI-generated, a useful reminder that the entire artifact is a fabricated teaching example. The citations are reproduced here exactly as they appear in the assignment:

Fabricated in-copy citations

  1. (a) "Knewvasive Izinferior, M.D., 'MAGEC vs. Spine,' The Fauci Journal, July 17, 2024." (fabricated)
  2. (b) "Mighspine Izbent, PhD, 'MAGEC Failure in S.P.D.,' Kansas Journal, August 12, 2020." (fabricated)
  3. (c) "Art Iscool, DO, MPH, 'Radiation and Rods,' New American Institution, March 1, 2014." (fabricated)

Image sources (disclosed as AI-generated)

  1. Figure 1: AI-generated image from Microsoft Designer.
  2. Figure 2: AI-generated image from OpenArt.AI.
  3. Figure 3: AI-generated image from Leonardo AI.
  4. Nikas, Aedan. "Seed Spine Market Strategy" (PowerPoint). Johns Hopkins, Washington, D.C., 08/04/2024.